Related Experiment Video
Updated: May 16, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
NANOGP8: evolution of a human-specific retro-oncogene
Daniel J Fairbanks1, Aaron D Fairbanks, T Heath Ogden
1Department of Biology, Utah Valley University, 800 W.University Parkway, Orem, UT 84058, USA. daniel.fairbanks@uvu.edu
The human NANOGP8 retrogene, a cancer-promoting gene, originated 0.9-2.5 million years ago from a NANOG variant. NANOGP8 is present in humans and Neanderthals, potentially explaining human cancer predisposition.
Area of Science:
- Evolutionary biology
- Genetics
- Oncology
Background:
- NANOGP8 is a human retrogene derived from NANOG, predominantly expressed in cancer cells and implicated in tumorigenesis.
- Its evolutionary origin and relationship with the parent NANOG gene, particularly in the context of human evolution and cancer, require further investigation.
Purpose of the Study:
- To precisely estimate the evolutionary origin of the human NANOGP8 retrogene.
- To investigate the specific NANOG allele from which NANOGP8 arose and its evolutionary fate.
- To determine the presence of NANOGP8 in Neanderthals and its implications for human cancer predisposition.
Main Methods:
- Comparative genomic analysis of human and Neanderthal sequences.
- Identification and characterization of fixed and polymorphic variants in NANOG and NANOGP8.
- Phylogenetic analysis to estimate evolutionary timelines.
Main Results:
- NANOGP8 originated approximately 0.9 to 2.5 million years ago, more recently than previously estimated.
- NANOGP8 arose from a NANOG allele with a 22-nucleotide deletion in the 3' UTR, which remains polymorphic.
- NANOGP8 is fixed in modern humans and was also present in Neanderthals.
- Some commonly used variants for distinguishing NANOG and NANOGP8 are unreliable due to polymorphism.
Conclusions:
- NANOGP8 is a human-specific retro-oncogene with an evolutionary history intertwined with human and Neanderthal populations.
- Its retrotransposition and potential regulation by nearby elements may contribute to cancer susceptibility in humans.
- The findings necessitate re-evaluation of diagnostic methods relying on NANOG/NANOGP8 sequence differences.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...